The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Malignant fungating wounds (MFW) are present in 5-14% of advanced cancer patients in the US. They often occur within the last 6 months of life and are associated with symptoms that make the lives of cancer patients increasingly difficult, serving as a major source of emotional distress and poor quality of life. Associations between the cutaneous microbiome of these wounds and severity of symptoms have been made and will be applied to the selection of treatment options used with these wounds.
Learning Objective:
The participant will be able to describe the microbiome of malignant fungating wounds with related symptoms and choose treatments to address common symptoms.
Speaker(s):
Stephanie
Yates,
MSN, RN, ANP-BC, CWOCN,
Nurse Practitioner - Oncology WOC Nurse,
Duke University Hospital Cancer Center
You must be logged in and own this session in order to
post comments.
